Tiadylt ER Alternatives Compared
| Tiadylt ER (diltiazem) | Furosemide | Carvedilol |
|
|---|
| Tiadylt ER (diltiazem) | Furosemide | Carvedilol |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Heart Failure, High Blood Pressure, Angina Pectoris Prophylaxis. Tiadylt ER may also be used for purposes not listed in this medication guide. |
Prescription only
Furosemide significantly increases urination which relieves excess fluid, but its use may also lead to the depletion of certain electrolytes in the body (such as potassium). Prescribed for Edema... View more |
Prescription only
Carvedilol blocks both alpha and beta receptors which lowers blood pressure and improves how the heart pumps blood. It is not usually recommended for people with pre-existing breathing problems... View more |
Related suggestions High Blood Pressure (Hypertension)
Heart Failure (Congestive Heart Failure)
|
|||||||||||||||||||||||
| More about (diltiazem) | More about Furosemide | More about Carvedilol | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Tiadylt ER has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Furosemide has an average rating of 6.8 out of 10 from a total of 121 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 21% reported a negative effect. |
Carvedilol has an average rating of 5.3 out of 10 from a total of 201 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Tiadylt ER side effects |
View all Furosemide side effects |
View all Carvedilol side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Lower cost generic approved |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Tiadylt ER prices |
View all Furosemide prices |
View all Carvedilol prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other diltiazem brands include: Cardizem, Cardizem CD, Cardizem LA, Cartia XT, Dilacor XR, Dilt-XR, Diltia XT, Diltiazem Hydrochloride CD, Diltiazem Hydrochloride SR, Diltiazem Hydrochloride XR, Diltzac, Matzim LA, Taztia XT, Tiazac View more | Diaqua-2, Furoscix, Lasix | Coreg, Coreg CR | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
6 hours |
1.5 hours |
3.1 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 709 drugs are known to interact with Tiadylt ER:
|
A total of 506 drugs are known to interact with Furosemide:
|
A total of 586 drugs are known to interact with Carvedilol:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
July 01, 1966 |
September 14, 1995 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.